EUVIMEDEUVIMED entdecken
Open Access

Association Between S-1 Treatment Duration and Disease Control in Advanced Non-small-cell Lung Cancer

Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Masaharu Iguchi

Cancer Diagnosis & Prognosis · 01.11.2026 · 6 (6) · 988-995

DOI: 10.21873/cdp.10601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 01.11.2026. Verfasst von Yutaka Takahara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Kanazawa Medical University, Uchinada-machi, Ishikawa, Japan. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim: S-1 monotherapy is used for a subset of patients with advanced non-small-cell lung cancer (NSCLC); however, predictors of prolonged treatment and survival remain unclear. The aim of this study was to investigate clinical factors associated with extended S-1 treatment and clinical outcomes in patients with advanced NSCLC. Patients and Methods: We retrospectively reviewed the data of 32 patients with stage IIIB/IV or recurrent NSCLC who received S-1 monotherapy at Kanazawa Medical University Hospital from January 2015 and December 2025. Patients were classified into a long-term treatment group (≥90 days, n=13) or a short-term treatment group (

Schlagwörter

Stichwörter der Autor:innen

Non-small-cell lung cancerS-1 monotherapydisease controloverall survivaltreatment duration

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Kanazawa Medical University, Uchinada-machi, Ishikawa, Japan.

Zitieren

APA

Takahara, Y., Abe, R., Nagae, S., Tanaka, T., Ishige, Y., Shionoya, I., Yamamura, K., & Iguchi, M. (2026). Association Between S-1 Treatment Duration and Disease Control in Advanced Non-small-cell Lung Cancer. Cancer Diagnosis & Prognosis, 6(6), 988-995. https://doi.org/10.21873/cdp.10601

Vancouver

Takahara Y, Abe R, Nagae S, Tanaka T, Ishige Y, Shionoya I, et al. Association Between S-1 Treatment Duration and Disease Control in Advanced Non-small-cell Lung Cancer. Cancer Diagnosis & Prognosis. 2026;6(6):988-995. doi:10.21873/cdp.10601

BibTeX
@article{Takahara2026,
  author = {Takahara, Yutaka and Abe, Ryudai and Nagae, Sumito and Tanaka, Takuya and Ishige, Yoko and Shionoya, Ikuyo and Yamamura, Kouichi and Iguchi, Masaharu},
  title = {Association Between S-1 Treatment Duration and Disease Control in Advanced Non-small-cell Lung Cancer},
  journal = {Cancer Diagnosis & Prognosis},
  year = {2026},
  volume = {6},
  number = {6},
  pages = {988--995},
  doi = {10.21873/cdp.10601}
}
Kostenlos starten →